2 interactions on record
Pralidoxime may potentiate atropine effect, causing earlier onset of atropinization signs (flushing, mydriasis, tachycardia, dryness of mouth/nose). Excitement and manic behavior post-consciousness recovery reported.
Source: NLP:atropine
Pralidoxime may potentiate the effect of atropine, causing signs of atropinization (flushing, mydriasis, tachycardia, dryness of mouth/nose) to occur earlier than expected. Excitement and manic behavior may follow recovery of consciousness.
Source: NLP:atropine sulfate injection usp, 0.5 mg/0.7 ml